Cardiac amyloidosis: hemodynamic, echocardiographic and endomyocardial biopsy studies

Area of Science:

• Cardiology
• Pathology
• Internal Medicine

Background:

• Cardiac amyloidosis is a progressive condition characterized by amyloid protein deposition in the heart.
• It can lead to diverse clinical presentations, including heart failure, angina, and arrhythmias.
• Diagnosis can be challenging due to nonspecific symptoms and imaging findings.

Purpose of the Study:

• To evaluate the clinical manifestations and diagnostic challenges of cardiac amyloidosis.
• To assess the utility of various diagnostic modalities in identifying cardiac amyloidosis.
• To highlight the definitive role of endomyocardial biopsy in diagnosis.

Main Methods:

• Retrospective analysis of six patients diagnosed with cardiac amyloidosis.
• Review of clinical presentations, electrocardiograms (ECG), chest roentgenograms, echocardiography, and cardiac catheterization findings.
• Confirmation of diagnosis through endomyocardial biopsy.

Main Results:

• Patients presented with varied symptoms, predominantly congestive heart failure.
• Non-cardiac clues were infrequent, and initial ECG, echocardiography, and angiography showed nonspecific or varied findings.
• Endomyocardial biopsy confirmed amyloid deposits in all six patients, establishing the diagnosis definitively.

Conclusions:

• Cardiac amyloidosis exhibits a wide spectrum of clinical presentations, necessitating a high index of suspicion.
• Non-invasive diagnostic methods have limited sensitivity for early detection.
• Endomyocardial biopsy remains the gold standard for accurate and safe diagnosis of cardiac amyloidosis.